44 related articles for article (PubMed ID: 2571966)
1. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon.
D'Emilia J; Bulovas K; D'Ercole K; Wolf B; Steele G; Summerhayes IC
Oncogene; 1989 Oct; 4(10):1233-9. PubMed ID: 2571966
[TBL] [Abstract][Full Text] [Related]
2. Reactivity of a human monoclonal antibody against carcinomas and other lesions of the colon.
Formenti SC; Mitchell MS; Taylor CR; Lipkin M; Jernstrom PH; Kan-Mitchell J
Cancer Immunol Immunother; 1989; 28(4):296-300. PubMed ID: 2467741
[TBL] [Abstract][Full Text] [Related]
3. New clinical trial design in precision medicine: discovery, development and direction.
Duan XP; Qin BD; Jiao XD; Liu K; Wang Z; Zang YS
Signal Transduct Target Ther; 2024 Mar; 9(1):57. PubMed ID: 38438349
[TBL] [Abstract][Full Text] [Related]
4. Lack of HER-2 gene amplification and association with pathological and clinical characteristics of differentiated thyroid cancer.
Mdah W; Mzalbat R; Gilbey P; Stein M; Sharabi A; Zidan J
Mol Clin Oncol; 2014 Nov; 2(6):1107-1110. PubMed ID: 25279206
[TBL] [Abstract][Full Text] [Related]
5. The interrelationship between HER2 and CASP3/8 with apoptosis in different cancer cell lines.
Arman K; Ergün S; Temiz E; Öztuzcu S
Mol Biol Rep; 2014 Dec; 41(12):8031-6. PubMed ID: 25189649
[TBL] [Abstract][Full Text] [Related]
6. Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma.
Khademi B; Khademi B; Ghaderi A; Hosseini SF; Niknejad N
Iran J Otorhinolaryngol; 2013 Jun; 25(72):161-8. PubMed ID: 24303437
[TBL] [Abstract][Full Text] [Related]
7. Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients.
Wang J; Hollingshead J; El-Masry N; Horncastle D; Talbot I; Tomlinson I; Alison MR; El-Bahrawy M
J Gastrointest Cancer; 2012 Sep; 43(3):444-55. PubMed ID: 21989899
[TBL] [Abstract][Full Text] [Related]
8. Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.
Takikita M; Xie R; Chung JY; Cho H; Ylaya K; Hong SM; Moskaluk CA; Hewitt SM
J Transl Med; 2011 Jul; 9():126. PubMed ID: 21801427
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.
Li Q; Wang D; Li J; Chen P
BMC Cancer; 2011 Jun; 11():277. PubMed ID: 21708009
[TBL] [Abstract][Full Text] [Related]
10. β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis.
Drebber U; Madeja M; Odenthal M; Wedemeyer I; Mönig SP; Brabender J; Bollschweiler E; Hölscher AH; Schneider PM; Dienes HP; Vallböhmer D
Int J Colorectal Dis; 2011 Sep; 26(9):1127-34. PubMed ID: 21538055
[TBL] [Abstract][Full Text] [Related]
11. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
Kavanagh DO; Chambers G; O'Grady L; Barry KM; Waldron RP; Bennani F; Eustace PW; Tobbia I
BMC Cancer; 2009 Jan; 9():1. PubMed ID: 19118499
[TBL] [Abstract][Full Text] [Related]
12. HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.
Park DI; Kang MS; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Han WK; Kim H; Ryu SH; Sepulveda AR
Int J Colorectal Dis; 2007 May; 22(5):491-7. PubMed ID: 16947041
[TBL] [Abstract][Full Text] [Related]
13. Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.
Asakura H; Takashima H; Mitani M; Haba R; Seo R; Yokoe K; Toyama Y; Ohkawa M
Int J Clin Oncol; 2005 Aug; 10(4):285-8. PubMed ID: 16136377
[TBL] [Abstract][Full Text] [Related]
14. HER2 is frequently over-expressed in ovarian clear cell adenocarcinoma: possible novel treatment modality using recombinant monoclonal antibody against HER2, trastuzumab.
Fujimura M; Katsumata N; Tsuda H; Uchi N; Miyazaki S; Hidaka T; Sakai M; Saito S
Jpn J Cancer Res; 2002 Nov; 93(11):1250-7. PubMed ID: 12460467
[TBL] [Abstract][Full Text] [Related]
15. Adrenocorticotropin-Producing Pituitary Carcinoma with Expression of c-erbB-2 and High PCNA Index: A Comparative Study with Pituitary Adenomas and Normal Pituitary Tissues.
Nose-Alberti V; Mesquita MI; Martin LC; Kayath MJ
Endocr Pathol; 1998; 9(1):53-62. PubMed ID: 12114662
[TBL] [Abstract][Full Text] [Related]
16. Expression of p185 and p53 in benign and malignant colorectal lesions.
Porcelli B; Frosi B; Terzuoli L; Arezzini L; Marinello E; Vernillo R; De Martino A; Vatti R; Minacci C
Histochem J; 2001 Jan; 33(1):51-7. PubMed ID: 11352401
[TBL] [Abstract][Full Text] [Related]
17. The neu oncogene product in serum and tissue of patients with metastatic gastrointestinal carcinomas.
Vogel W; Kath R; Kosmehl H; Olschowsky E; Höffken K
J Cancer Res Clin Oncol; 1996; 122(2):118-21. PubMed ID: 8576278
[TBL] [Abstract][Full Text] [Related]
18. C-erbB-2 immunostaining: problems with interpretation.
Kay EW; Walsh CJ; Cassidy M; Curran B; Leader M
J Clin Pathol; 1994 Sep; 47(9):816-22. PubMed ID: 7962650
[TBL] [Abstract][Full Text] [Related]
19. SSO Clinical Award Lecture. The surgical oncologist as a key translator of basic biology to patients with gastrointestinal cancer: asking the right questions.
Steele G
Ann Surg Oncol; 1994 May; 1(3):262-9. PubMed ID: 7842296
[No Abstract] [Full Text] [Related]
20. c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.
Hardwick RH; Shepherd NA; Moorghen M; Newcomb PV; Alderson D
J Clin Pathol; 1995 Feb; 48(2):129-32. PubMed ID: 7745111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
